(19)
(11) EP 4 511 054 A2

(12)

(88) Date of publication A3:
30.11.2023

(43) Date of publication:
26.02.2025 Bulletin 2025/09

(21) Application number: 23792786.8

(22) Date of filing: 20.04.2023
(51) International Patent Classification (IPC): 
A61K 38/20(2006.01)
A61P 35/00(2006.01)
A61K 38/19(2006.01)
A61K 38/16(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 14/54; C07K 2319/30; C07K 2319/31; C12N 15/62; A61K 38/00
(86) International application number:
PCT/US2023/066016
(87) International publication number:
WO 2023/205738 (26.10.2023 Gazette 2023/43)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 20.04.2022 US 202263333085 P
20.04.2022 US 202263333090 P

(71) Applicant: Neptune Biosciences LLC
Newark, CA 94560 (US)

(72) Inventors:
  • KILLEEN, Nigel
    Hillsborough, CA 94010 (US)
  • BESKE, Oren
    Aromas, CA 95004 (US)
  • VOLLRATH, Benedikt, K.
    San Diego, CA 92107 (US)
  • GOVINDARAJAN, Sridhar
    Los Altos, CA 94024 (US)

(74) Representative: Forresters IP LLP 
Skygarden Erika-Mann-Straße 11
80636 München
80636 München (DE)

   


(54) ORTHOGONAL IL-21 RECEPTOR/CYTOKINE SYSTEMS